Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

about

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q53323484

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

@en

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

@nl

type

Item

label

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

@en

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

@nl

prefLabel

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

@en

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer.

@nl

P1476

Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer

@en

P2093

Hye-Jeong Lee

http://www.w3.org/2001/XMLSchema#string

Jae Seok Lee

http://www.w3.org/2001/XMLSchema#string

Sae Rom Hong

http://www.w3.org/2001/XMLSchema#string

Yoo Jin Hong

http://www.w3.org/2001/XMLSchema#string

Young Jin Kim

http://www.w3.org/2001/XMLSchema#string

Yun Jung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer

Management of lung cancer in older adults.

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival.

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients.

Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients

Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.

Computed tomographic fluoroscopy-guided needle aspiration biopsy as a second biopsy technique after indeterminate transbronchial biopsy results for pulmonary lesions: comparison with second transbronchial biopsy.

Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer.

Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutation.

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.

P2888

s13277-015-4034-6

P304

3205-3213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-4034-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26432331

http://www.w3.org/2001/XMLSchema#string